Associate Health Minister David Seymour welcomes Pharmac's funding of oestradiol gel.
The New Zealand Government has welcomed the decision by Pharmac to fund oestradiol gel, a hormone treatment that has seen global shortages in recent years. The shortage was caused by an increase in demand, with over tripled usage in the past three years.
According to Associate Health Minister David Seymour, the funding of oestradiol gel is a response to the voices of patients who have been affected by the shortage. "I'm pleased to see Pharmac's responsiveness to the voices of patients," he said. The minister acknowledged that it has been a difficult time for those needing the medication and commended Pharmac on its efforts.
Oestradiol gel will now be available as a substitute for those in need, providing welcome relief for patients who have struggled with the shortage. Mr Seymour stated that this decision reflects the Government's commitment to a more adaptable and patient-centered approach.
The funding of oestradiol gel is seen as an important step towards building a world-class health system, which requires access to world-class medicines. As the country continues to navigate global healthcare challenges, this move demonstrates the Government's dedication to addressing these issues head-on.